English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduIMPORTANT UPDATE:
The article referenced in Tip #4 on color ultrasound for suspected GCA will not be published on April 30. If you had planned to cover this topic, please hold your stories until further notice. In its place, Annals will publish the following:
Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease Abstract: https://www.acpjournals.org/doi/10.7326/M23-1874
Please contact Angela Collom at [email protected] or 609-367-4225 with questions or for an embargoed PDF. Thank you.
[PLEASE DISREGARD. CONTENT TO BE PUBLISHED AT A LATER DATE]
Ultrasound may be viable first-line diagnostic tool for persons with suspected GCA
Abstract: https://www.acpjournals.org/doi/10.7326/M23-3417
URL goes live when the embargo lifts
Researchers from the Centre Hospitalier Rochefort, Rochefort, France, conducted a prospective cohort study of 165 patients with high clinical suspicion of GCA. The authors examined the use of color Doppler ultrasound of the temporal artery as a first-line diagnostic test and temporal artery biopsy (TAB) as a secondary test. The authors found that a diagnosis of GCA was confirmed in 44%, 17%, and 21% of patients by ultrasound, TAB, and clinical expertise and/or other imaging tests, respectively. According to the authors, their findings show that the use of temporal artery ultrasound may be an efficient way to make the diagnosis of GCA in patients with high clinical suspicion and to reduce imaging costs and the need for biopsy, thereby limiting complications and the need for a surgeon.
Media contacts: For an embargoed PDF, please contact Angela Collom at [email protected]. To speak with the corresponding author, Guillaume Denis, MD, please contact [email protected].
